Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.93% | -1.93% | -3.88% | -3.88% | -1.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.93% | -1.93% | -3.88% | -3.88% | -1.68% |
| Cost of Revenue | 4.27% | 4.27% | -6.03% | -6.03% | -4.38% |
| Gross Profit | -5.66% | -5.66% | -2.50% | -2.50% | 0.01% |
| SG&A Expenses | 0.89% | 0.89% | 0.00% | 0.00% | 7.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -26.82% | -26.82% | 74.04% | 74.04% | 148.53% |
| Total Operating Expenses | 1.65% | 1.65% | -1.99% | -1.99% | 2.37% |
| Operating Income | -39.98% | -39.98% | -22.80% | -22.80% | -30.81% |
| Income Before Tax | -19.91% | -19.91% | 8.66% | 8.66% | -28.98% |
| Income Tax Expenses | 84.35% | 84.35% | -1.27% | -1.27% | -21.96% |
| Earnings from Continuing Operations | -31.93% | -31.93% | 10.27% | 10.27% | -29.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.82% | -13.82% | 8.25% | 8.25% | -2,039.66% |
| Net Income | -41.33% | -41.33% | 12.49% | 12.49% | -42.05% |
| EBIT | -39.98% | -39.98% | -22.80% | -22.80% | -30.81% |
| EBITDA | -29.20% | -29.20% | -16.73% | -16.73% | -19.31% |
| EPS Basic | -41.03% | -41.03% | 11.85% | 11.85% | -42.08% |
| Normalized Basic EPS | -31.08% | -31.08% | -18.28% | -18.28% | -47.14% |
| EPS Diluted | -41.88% | -41.88% | 11.85% | 11.85% | -41.79% |
| Normalized Diluted EPS | -31.08% | -31.08% | -18.28% | -18.28% | -46.76% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.20% | 0.20% | 0.22% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.18% | 0.18% | -0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.20% | -0.20% | -- |